Clinical trials for a laser treatment targeting this common eye disease will begin in Finland next spring, and researchers hope it could become available to patients within three years. About one in ...

Around a third of people over the age of 80 suffer from age-related macular degeneration (AMD), with an estimated 20 million ...

A small wireless chip and a pair of smart glasses are offering new hope to people who thought they’d never read again. The ...

Revolutionary retinal implant restores central vision in 80% of patients with advanced macular degeneration, offering hope ...

For the first time, scientists have managed to restore central vision loss from an irreversible age-related eye condition via ...

SOL-R, the second registrational trial of AXPAXLI™ in wet AMD, remains on track for topline data in 1H 2027Together with SOL-1, these ...

A photovoltaic retinal implant shows promise as a way to improve vision in patients with advanced age-related macular ...

A Guernsey resident believes "people's enjoyment in life" is being sacrificed for the financial cost of using a drug that can ...

A tiny wireless chip implanted in the back of the eye and a pair of high-tech glasses have partially restored vision to ...

Recent Investor Day highlighted how AXPAXLI™ is positioned to redefine retina based on potential superiority label, market expansion, and ...

A new trial shows that a wireless subretinal implant, the PRIMA system, restored central vision in patients with geographic ...